Cargando…
Gut as a source of new β‐cells and Segi's cap
A deficit of β‐cells is a salient feature in both type 1 and type 2 diabetes mellitus. Due to the absolute lack of supplying β‐cells for organ or cell transplantation, there is an urgent need to explore the efficient method to generate insulin‐producing cells. Cell conversion of intestinal cryptic e...
Autor principal: | Yagihashi, Soroku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286784/ https://www.ncbi.nlm.nih.gov/pubmed/37132053 http://dx.doi.org/10.1111/jdi.14025 |
Ejemplares similares
-
Quo vadis: Where have the β-cells gone?
por: Yagihashi, Soroku, et al.
Publicado: (2015) -
Imaging of insulin factory: Is it just imagination or approaching reality?
por: Yagihashi, Soroku
Publicado: (2012) -
What can we learn from the islet of Joslin Medalists?
por: Yagihashi, Soroku
Publicado: (2020) -
Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
por: Mizukami, Hiroki, et al.
Publicado: (2014) -
Dynamic pathology of islet endocrine cells in type 2 diabetes: β‐Cell growth, death, regeneration and their clinical implications
por: Yagihashi, Soroku, et al.
Publicado: (2015)